Robotic telepresence gain acceptance during ocular evaluations

Article

The COVID-19 pandemic has led to greater comfort with robotic telepresence in eye screenings.

Reviewed by Priya Tailor, BA.

Robotic telepresence gain acceptance during ocular evaluations

Telemedicine came into its own during the COVID-19 pandemic. Before the pandemic in 2019, approximately 43% of medical centres in the United States were capable of telemedicine use, in contrast to 95% that reported use in 2020.

New research indicates that this scenario has resulted in greater patient acceptance of robotic telepresence (RT; Double Robotics), a mobile videoconferencing tool, during ocular examinations. In turn, this facilitates the continued use of such modalities to improve patient access to care in communities where care may be minimal, according to lead study author Priya Tailor, BA, and colleagues from the Institute of Ophthalmology and Visual Science at Rutgers New Jersey Medical School in Newark.

“RT in particular has proven useful in patient triage and can improve health care access,” the investigators said. In light of the rapid acceptance of this type of examination, Tailor and colleagues conducted a study to identify changes in patients’ attitudes toward physician teleconsultations using RT during vision-threatening disease screenings before and during the COVID-19 pandemic.

Testing the waters

RT was implemented in a community-based eye screening protocol before and after the emergence of the pandemic. Twenty-five subjects were included from July to October 2019 (mean age, 32 years; 44% women) and 40 subjects from June to October 2021 (mean age, 56 years; 55% women).

Screening volunteers measured blood pressure, visual acuity, and intraocular pressure and obtained 45° nonmydriatic retinal images and optical coherence tomography B-scans. The scans were reviewed by an off-site glaucoma or retina subspecialist using either remote desktop software or cloud-based software. The subjects later interacted with a specialist via RT and completed a 5-point survey on their consultation, Tailor explained.

The patient experience

The investigators found that the average patient comfort level with RT increased significantly (P = .038) during the pandemic. The mean values during the 2 periods of time were 4.48 before and 4.80 during the pandemic; there was a 22.5% increase in the proportion of subjects reporting 5/5 comfort.

Subject age appeared to be a relevant factor in the response to the use of RT. “Older individuals were less likely to report higher comfort before the pandemic (odds ratio [OR], 0.903; P = .014) and more likely during the pandemic (OR, 1.075; P = .023). No significant difference in comfort between genders was seen in either group (P > .7).

“With telemedicine continuing to expand in health care, our results are highly relevant and exciting,” Tailor said. “After the pandemic, even among those individuals [who] reported preference for the in-person consult, the average comfort rating was 4.68/5.”

This indicates suitability for continued use in community screenings, Tailor explained. “It further paves the way for long-term telemedicine use by health care centres and additional studies on [the use] of telepresence in triage, ophthalmology clinic operations, and medical education,” she said.

“To our knowledge, this study is the first to compare subjects’ attitudes toward a real-time telemedicine intervention before and after the pandemic,” the authors said. “We demonstrated that COVID-19 has led to greater comfort with RT in eye screenings. Telemedicine should continue to be implemented in medical centres and community screenings long beyond the current pandemic, as it is an excellent avenue for connecting remote and underserved communities with valuable subspecialty care.”

Priya Tailor, BA
E: pst24@njms.rutgers.edu
Tailor has no financial disclosures related to this content.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.